AcelRx pain treatment meets late-stage study goals

by admin on May 21, 2013

Shares of AcelRx Pharmaceuticals Inc. hit an all-time high price Tuesday, after the specialty drugmaker said its NanoTab pain treatment system met its main goal in late-stage research, and the company …

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: